PT93166A - Metodo para a producao de antigenios de celulas dos ilheus pancreaticos - Google Patents

Metodo para a producao de antigenios de celulas dos ilheus pancreaticos

Info

Publication number
PT93166A
PT93166A PT93166A PT9316690A PT93166A PT 93166 A PT93166 A PT 93166A PT 93166 A PT93166 A PT 93166A PT 9316690 A PT9316690 A PT 9316690A PT 93166 A PT93166 A PT 93166A
Authority
PT
Portugal
Prior art keywords
iddm
cell antigens
ica
pancreatic
cells
Prior art date
Application number
PT93166A
Other languages
English (en)
Other versions
PT93166B (pt
Inventor
Daniel Rabin
Original Assignee
Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Diagnostics Inc filed Critical Molecular Diagnostics Inc
Publication of PT93166A publication Critical patent/PT93166A/pt
Publication of PT93166B publication Critical patent/PT93166B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT93166A 1989-02-17 1990-02-15 Metodo para a producao de antigenios de celulas dos ilheus pancreaticos PT93166B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31254389A 1989-02-17 1989-02-17
US44170389A 1989-12-04 1989-12-04

Publications (2)

Publication Number Publication Date
PT93166A true PT93166A (pt) 1990-08-31
PT93166B PT93166B (pt) 1997-11-28

Family

ID=26978437

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93166A PT93166B (pt) 1989-02-17 1990-02-15 Metodo para a producao de antigenios de celulas dos ilheus pancreaticos

Country Status (14)

Country Link
EP (1) EP0383129B1 (pt)
JP (1) JP2858467B2 (pt)
AT (1) ATE122394T1 (pt)
AU (1) AU626636B2 (pt)
CA (1) CA2010275C (pt)
DE (1) DE69019190T2 (pt)
DK (1) DK0383129T3 (pt)
ES (1) ES2072928T3 (pt)
FI (1) FI103730B (pt)
GR (1) GR3017019T3 (pt)
IE (1) IE66997B1 (pt)
IL (1) IL93397A (pt)
NO (1) NO306996B1 (pt)
PT (1) PT93166B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645998A (en) * 1988-12-13 1997-07-08 University Of Florida Research Foundation Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US6001360A (en) * 1988-12-13 1999-12-14 University Of Florida Method and compositions for early detection and treatment of insulin dependent diabetes mellitus
JPH02200700A (ja) * 1989-01-30 1990-08-08 Shionogi & Co Ltd 新規ｒｅｇ蛋白質
US5175085A (en) * 1990-02-20 1992-12-29 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus
US5427940A (en) * 1991-06-03 1995-06-27 Board Of Regents, The University Of Texas System Engineered cells producing insulin in response to glucose
US5744327A (en) * 1990-02-20 1998-04-28 Board Of Regents, The University Of Texas System Methods for producing insulin in response to non-glucose secretagogues
ATE268908T1 (de) 1990-09-07 2004-06-15 Univ California Verfahren zur diagnose und behandlung von diabetes
US5998366A (en) * 1990-09-21 1999-12-07 The Regents Of The University Of California Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
US6682906B1 (en) 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
AU8864791A (en) * 1990-10-02 1992-04-28 Trigen Incorporated Antibodies and methods for diagnosis and treatment of diabetes
AU671589B2 (en) * 1991-05-15 1996-09-05 Board Of Regents Of The University Of Washington, The Cloning and expression of human islet glutamic acid decarboxylase autoantigen
US5792656A (en) * 1991-06-03 1998-08-11 Board Of Regents, The University Of Texas System Methods of preparing genetically engineered cells that produce insulin in response to glucose
WO1993016725A1 (en) * 1992-02-27 1993-09-02 The Board Of Trustees Of The Leland Stanford Junior University Early antigen for autoimmune diabetes
US5200318A (en) * 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents
WO1996038479A1 (fr) * 1995-05-30 1996-12-05 Fujisawa Pharmaceutical Co., Ltd. Procede de diagnostic du diabete sucre insulino-dependant et kit de diagnostic
EP0929683A1 (en) 1996-03-06 1999-07-21 ZymoGenetics, Inc. DIABETES MELLITUS 37 kD AUTOANTIGEN PROTEIN-TYROSINE PHOSPHATASE
CA2288343A1 (en) * 1997-04-25 1998-11-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CN110244051A (zh) * 2019-07-05 2019-09-17 许昌学院 一种用于糖尿病的多组分标记免疫检测系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0084796B1 (en) * 1982-01-22 1990-05-02 Cetus Corporation Hla typing method and cdna probes used therein
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
CA1314811C (en) * 1985-06-14 1993-03-23 Gerald T. Nepom Methods for identifying alleles associated with increased risk of diabetes
CA1327162C (en) * 1987-04-09 1994-02-22 Board Of Trustees Of The Leland Stanford Junior University (The) Method for prophylactically treating an individual for an autoimmune disease
DE3854741T3 (de) * 1987-06-24 2002-08-14 Autoimmune, Inc. Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.

Also Published As

Publication number Publication date
CA2010275C (en) 2000-08-29
AU4988390A (en) 1990-08-23
PT93166B (pt) 1997-11-28
GR3017019T3 (en) 1995-11-30
IL93397A0 (en) 1990-11-29
DK0383129T3 (da) 1995-10-09
CA2010275A1 (en) 1990-08-17
DE69019190T2 (de) 1995-09-14
JPH0347133A (ja) 1991-02-28
IL93397A (en) 1997-06-10
FI103730B1 (fi) 1999-08-31
IE66997B1 (en) 1996-02-21
AU626636B2 (en) 1992-08-06
EP0383129B1 (en) 1995-05-10
DE69019190D1 (de) 1995-06-14
IE900589L (en) 1990-08-17
JP2858467B2 (ja) 1999-02-17
FI900759A0 (fi) 1990-02-15
ES2072928T3 (es) 1995-08-01
ATE122394T1 (de) 1995-05-15
EP0383129A2 (en) 1990-08-22
NO900474L (no) 1990-08-20
EP0383129A3 (en) 1991-07-31
FI103730B (fi) 1999-08-31
NO306996B1 (no) 2000-01-24
NO900474D0 (no) 1990-02-01

Similar Documents

Publication Publication Date Title
PT93166A (pt) Metodo para a producao de antigenios de celulas dos ilheus pancreaticos
ATE87655T1 (de) Markierer der t-zelle aktivierung.
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
NO904919L (no) Materiale for diagnostisering og behandling av insulinavhengig diabetes mellitus samt fremstilling av slikt materiale.
DK113389A (da) Monoklonale antistoffer
ES2075196T3 (es) Metodo para el uso y la sintesis de peptidos.
NO975435L (no) Modifiserte/kimeriske proteiner samt anvendelse derav
EP0330506A3 (en) Vla proteins
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
ATE101345T1 (de) Selektive entfernung von immunkomplexen.
EP0869177A3 (en) Human a- and b- platelet-derived growth factor receptor proteins and uses therefor.
DE3879881D1 (de) Rekombinante hiv-2 polypeptide.
AU612683B2 (en) Synthetic peptides, antibodies directed against them, and the use thereof
EP0293827A3 (en) Assay for leishmaniasis
EP0177814A3 (en) Peptide antibodies and their use in detecting oncogene products
WO1992007939A3 (en) Polypeptide with 46kd hmfg differentiation antigen binding specificity
IE860758L (en) Anaplasma marginale subunit antigen for vaccination and¹diagnosis
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
FI102381B1 (fi) Epstein-Barrin viruksen tuma-antigeeniin (EBNA) liittyviä synteettisiä polypeptidejä ja menetelmä anti-EBNA-vasta-aineiden tunnistamiseksi kudosnäytteessä

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19970829

TE3A Change of address (patent)
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990228

NF3A Restitutio in integrum

Free format text: 19990830 RESTITUTIO IN INTEGRUM

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120829